Our Sole Focus is Acute Blood Purification (ABP)

Continuous renal replacement therapy (CRRT) is any extracorporeal blood purification therapy intended to substitute for impaired renal function over an extended period of time and applied 24 hours per day.

Nikkiso Acute Blood Purification is a global market leader focused on ABP, incorporating CRRT and other Extracorporeal Blood Purification Therapies. At Nikkiso, we provide equipment and supplies that optimise patient care, improve clinical efficiency and reduce costs over the life cycle of the machine. In today’s healthcare environment, we understand the need to consistently improve patient outcomes, ensure patient safety as well as improve cost-effectiveness. Our goal is to build and maintain the trust and peace of mind of the clinicians who use our products by providing therapies, services, and training which provide tangible value to critical care patient treatment.

Nikkiso Acute Blood Purification’s large portfolio is led by the Aquarius™ System with Regional Citrate Anticoagulation (RCA) and includes a wide range of haemofilters, plasmafilters and tubing sets that allow physicians to select the right product for each patient.